Kevin M. Forrest, Ph.D. joined 5AM Ventures in 2005 from Princeton University where he studied RNA-based regulatory processes. His work has been published in Current Biology, Development, and Developmental Cell. Prior to Princeton, Dr. Forrest was a summer fellow at the National Institutes of Health where he studied the genetics of human stuttering. Dr. Forrest previously served as a due diligence advisor to ProQuest Investments. Dr. Forrest currently represents 5AM as a Board Observer to Flexion, Marcadia, Relypsa, Synosia and Variation. Dr. Forrest holds a B.S. in Biology from Boston College and a Ph.D. in Molecular Biology from Princeton University. Dr. Forrest is based in the Waltham, MA office.